Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes

from Primary Care Update · host Mark Ebell

A whole lotta diabetes goin' on: linagliptin ($780) vs glimepiride ($3) for T2DM (https://www.ncbi.nlm.nih.gov/pubmed/31536101); semaglutide in T2DM + vascular/CKD (https://www.ncbi.nlm.nih.gov/pubmed/31185157); and whether we should care about pre-diabetes (https://www.ncbi.nlm.nih.gov/pubmed/31076416).

Episode metadata supplied by the publisher feed · Published Nov 14, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 31: T2DM treatment, T2DM with CVD or CKD, and pre-diabetes

0:00 28:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Primary Care Update?

This episode is 28 minutes long.

When was this Primary Care Update episode published?

This episode was published on November 14, 2019.

Can I download this Primary Care Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!